Ziihera
Pharma

Jazz’s Ziihera nets FDA nod in first-line HER2+ stomach cancer

Jefferies analysts recently put Ziihera’s peak sales at $1.5 billion in gastroesophageal adenocarcinoma alone.
Angus Liu Aug 25, 2026 11:06am
When is the new who The importance of timing in HCP marketing

When is the new who in HCP marketing

Brought to you by Phreesia Network Solutions
Connection together puzzle pieces Concept of business strategy collaboration

McKesson acquires Maryland CRO for $2.25 billion

Aug 25, 2026 11:22am
Bausch Health headquarters formerly Valeant

Despite trial miss, Bausch + Lomb advances combo to ph. 3

Aug 25, 2026 10:46am
Moran Texas House
Favicon Fierce Biotech

Why a congressman says China is 'beating us on our ground game'

Aug 25, 2026 9:45am
JNJ

FDA endorses J&J’s Imaavy to treat rare anemia disorder

Aug 25, 2026 9:20am
More News

Lundbeck partners with Eversana to broaden AI scope

Aug 25, 2026 8:00am

NAD reaches split decision on Kenvue-Hims & Hers hair ad row

Aug 25, 2026 3:38am

Courts reject Medicare price negotiation lawsuits from Merck, AZ

Aug 24, 2026 3:47pm

Hansa eyes US listing ahead of FDA verdict on Idefirix

Aug 24, 2026 2:45pm